Excelsior Sciences Funding: $95M Raised, Series A (2025)
Excelsior Sciences is based in New York. It has raised $95M in total funding. Latest round: Series A.
Excelsior Sciences funding overview
Excelsior Sciences is based in New York. Excelsior Sciences has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Excelsior Sciences runs through 2025; nothing later has been disclosed. Investors on record include Deerfield Management, Khosla Ventures, Sofinnova Partners, Cornucopian Capital, Eli Lilly and Company, Illinois Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Excelsior Sciences at a glance
Total raised
$95M
Latest round
Series A
Latest round date
December 2025
Headquarters
New York
Notable investors
Deerfield Management, Khosla Ventures, Sofinnova Partners, Cornucopian Capital, Eli Lilly and Company, Illinois Ventures, MIT
Frequently asked about Excelsior Sciences funding
How much has Excelsior Sciences raised?
Excelsior Sciences has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Excelsior Sciences?
Deerfield Management, Khosla Ventures, Sofinnova Partners, Cornucopian Capital, Eli Lilly and Company, Illinois Ventures are named among the investors backing Excelsior Sciences.
What was the latest Excelsior Sciences funding round?
The most recent disclosed round is a Series A, announced in December 2025.
Where is Excelsior Sciences based?
Excelsior Sciences is based in New York.
When did Excelsior Sciences last raise?
The last disclosed Excelsior Sciences round closed in December 2025 at Series A.
Excelsior Sciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
